Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF3YG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,115
Award facts
- Contract value 100% obligated
- $21,115.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,115.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, with completion scheduled for January 21, 2026. The contract covers the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 mL), a typhoid vaccine product, with performance based in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a task order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains extensive federal contract experience across multiple therapeutic domains and demonstrates consistent capability to fulfill government requirements for pharmaceutical products, vaccines, and medical supplies through competitive procurement processes. This particular delivery order aligns with the Defense Logistics Agency's broader pharmaceutical supply chain mission to provision military treatment facilities and other federal healthcare institutions with essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26FF3YG?
SPE2DR26FF3YG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FF3YG worth?
The government has obligated $21,115 on SPE2DR26FF3YG.
Is contract SPE2DR26FF3YG an order under another contract?
Yes. SPE2DR26FF3YG is a delivery order under SPE2DR25D3111, an indefinite delivery contract.
Was contract SPE2DR26FF3YG competed?
The extent of competition for SPE2DR26FF3YG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award